Magnetic water in medical practice

Professor Yuri Tkachenko.

A magnet is one of the oldest discoveries made by humans. In nature, it is in the form of magnetic iron ore. From time immemorial, magnet has been amazing in people. Its ability to attract and repel made even the most ancient civilizations consider it as a special creation of nature.

Ancient civilizations knew about the healing properties of the magnet. According to the Chinese, magnetotherapy is mentioned in the “Book of the Yellow Emperor on Private Medicine,” which is believed to have been written around 2000 BC. e.

The fact that we live in a magnetic field and the earth itself is a giant magnet was also discovered hundreds of years ago. Various authoritative experts believe that the Earth's magnetic field has a beneficial effect on the health of all animals, plants and people.

If in the days of the most ancient civilizations the Earth’s magnetic field was calm and non-discharged, today the same cannot be said about it. Power lines, household appliances (televisions, radios, microwave ovens, etc., which are all the creations of human hands), etc. significantly affect the Earth’s magnetic field, reducing its intensity.

In the twentieth century. magnetotherapy has everywhere attracted public attention. In Japan, the effect of using magnets to control and curb various diseases has been the subject of intense research. Now Japan has a leading position in the world in this area. Magnetic beds are very popular in the country. More than ten million Japanese people use them to relieve stress and nourish the body with energy. According to Japanese experts, magnets are especially indispensable for overwork, sciatica, and body tunnel syndrome, which is especially common among computer users, asthma, migraines, etc.

From Japan, this type of treatment came to the West, where he found many ardent adherents, including psychologists, doctors, physiotherapists, athletes, etc. Magnetotherapy received support from leading authorities in the field of medicine, for example, Dr. William Philpot from Oklahoma, USA, - a leading neurologist who, after several years of research, said that if you act on our body with a negative magnetic field, it stimulates the sleep hormone, melatonin, and thus provides a more restful sleep.

Jim Colbert, the U.S. golf champion, says that even his damaged disc does not hurt him if he uses magnetic pads. Even the US Food and Drug Administration has authorized its use and sale of various magnetic devices in the United States.

Experiments conducted by the University of Lomalinda (USA) and several other universities have established that the occurrence of many joint diseases and chronic diseases is associated with insufficient blood circulation and impaired nervous system. If the cells do not receive the necessary nutrients, this eventually leads to some kind of chronic disease. Now, studies of magnets are ongoing in various parts of the world, and since 1960 more than 4,000 medical and scientific works on the use of the magnet for medicinal purposes have been published.

A huge contribution to the research and practical application of magnetologists, in medical practice, was made by scientists of the Soviet Union, and then Russia.

(Novosibirsk, Nauka, 1978, 296) the work of Soviet scientists from Novosibirsk A. Buchachenko, R. Sagdeev, K. Salikhov was published. Magnetic and spin effects in chemical reactions.

At the same time, the Institute of Chemical Physics im. N.N. Semenova RAS, Moscow.

All-Union Research Thermotechnical Institute named after F.E. Dzerzhinsky (VTI)


Moscow Technological Institute of Food Industry.



Institute of Balneology and Physiotherapy - Sochi.

During this period, a special problem commission was created at the USSR Ministry of Health on magnetology.

The Academician-Anatoly Maryanovich Demetsky headed this commission.

The legendary teacher, a world-famous scientist, a doctor who began to use magnets in the treatment of partisans in the forests of Belarus during the Great Patriotic War!

Naturally, after such breakthrough publications, results, and reports, dozens of scientific research institutes SSSSR

And then Russia, opened scientific research topics in various areas in industry, medicine, and in agriculture.

As a result of these works, with conclusive evidence of the appropriateness of using magnetic fields, in 1993, ---

Resolution of the Council of Ministers - Government of the Russian Federation of October 14, 1993 N 1058

"On the development of scientific and production activities in the field of magnetology;

In the early stages of research, a magnet and magnetic water were used to relieve pain and neutralize inflammatory processes.

But at present, the use of magnetic water, and magnetic therapy, has a huge demand and a very wide range of applications.

Usually a magnet is used to relieve pain and inflammation. It seems that in the presence of a magnetic field, tissues work more vigorously. If you attach a magnet, then the blood circulation of the corresponding part of the body and around it increases. Exposure to a magnetic field allows tissues to absorb more oxygen. Thus, due to magnetic fields, tissues are activated, as a result of which waste is removed faster, and tissues absorb nutrients more efficiently. Therefore, the work of cells improves.

Each water molecule in the human body is polarized. This means that one part of it is electrically more positive, and the other is more negative. Polarization is closely related and interacts with magnetic fields. Thus, every cell created from these water molecules has a negative and positive field. At night, the negative magnetic energy of the Earth is stronger, which is expressed in a strengthening sleep, biological treatment and recharging with energy. When the sun rises, we are exposed to positive magnetic energy (the energy of the North Pole), helping us maintain daily activity. So, during the day we are influenced by the North Pole, and during the night we are affected by the South Magnetic Pole.

It seems obvious that the magnet, very reminiscent of these water, helps with any disease. Currently, magnets are widely used around the world to treat sleep disorders, relieve pain, and relieve inflammation.

One of the advantages of magnetotherapy is that it is cheap and has no side effects. Dr. Philpot, who received his doctorate in medicine from the University of Lamalinda, heads the Bio-Electromagnetic Institute in Oklahoma (USA). He claims that the human body itself is an electromagnetic machine.

Each cell of the body has a positive and negative field. The magnetic field of the Earth plays a crucial role in all types of activities on our planet, it supports the life of living beings and gives them strength. It is the magnetism of the Earth that activates the necessary enzyme systems in fruits and vegetables, which makes possible their normal maturation. For 24 hours, the human body is exposed to both positive and negative magnetic forces. The pineal gland in the head is responsible for the work of hormones and enzymes. It can be called a magnetic organ, since it contains magnetite crystals. It is highly sensitive to magnetic energy. At night, when the negative magnetic field of the Earth prevails, it is this gland that produces the hormone melatonin.

When we age, we produce less of these hormones, but the paradox is that the body needs the same amount of melatonin for sound sleep and health. Therefore, to increase the formation of this hormone, it is necessary to use magnets. Since hormones are produced by the body itself, they are completely harmless. When the body produces them in smaller quantities, the aging process begins.

Now let's see what other leading experts say about magnetotherapy. Magnetotherapy, in addition to being lightweight, effective and inexpensive, also provides a complete guarantee of safety. We give reviews about the magnetotherapy of some doctors.

Medical Doctor Louis Donnet, “Magnets for Your Health”:

“In Japan and various other parts of Asia, as well as in Europe, magnetotherapy has become a form of traditional medicine, a credible way of self-medication.”

Richard Leviton, Healing by the Energy of Nature, East - West Journal, June 1986:

“Now we are on the verge of a new era in the science of magnets and its application. A magnet is a tool given to us by Mother Nature herself. ”

Dr. Ralph W. Sierra, The Healing Power of a Magnet:

“Thanks to the amazing results achieved with magnetotherapy, she deserves to occupy an important place in the therapeutic field.” Neville S. Bengali, MD, author of the book “Magnetotherapy: Theory and Practice”:

“This is a revolution in the treatment of muscle damage, joint pain and posture problems. We treated 4,000 patients with magnets, and in 80% of cases we got a positive result. ”

Dr. D. B. Behren, from a presentation at a medical conference at Baylor College of Medicine, Texas:

Magnetic water in the service of doctors.

About 70% of the human body is water. Every month, almost all of the water in the body is replaced by a new one, so from eating magnetized water with phenomenal properties, you need to wait for the corresponding phenomenal results. Based on the increase in the dissolving properties and the fluidity of magnetized water, its bactericidal and other unusual properties, it is logical to assume that a powerful cleansing of the body with regular use of magnetic fluid: liver and kidneys from stones, spine and joints from salts, vessels from salts and fats, should occur and, finally, the intestines from toxins and the body as a whole from harmful microbes.

Experiments conducted by physicians and physicists over a century and a half have indeed shown that the use of magnet-treated water increases the permeability of biological membranes of tissue cells, reduces the amount of cholesterol in the blood and liver, lowers blood pressure, improves metabolism, and helps to remove small kidney stones. slow down skin aging, hair loss and normalize weight. Magnetic water has been used in medicine for more than 20 years for physiotherapeutic procedures in the treatment of diseases of the gastrointestinal tract, with circulatory disorders, skin, viral, ophthalmic diseases, to improve the functioning of the liver and lower extremities, with hepatitis, toxicosis, anemia, as an anti-inflammatory agent. Magnetized water accelerates the healing of various wounds and frostbitten parts of the body. Depending on the disease, water in a magnetized form is used both for external exposure and for internal use. Swimming in pools, baths, showers with such water relieve fatigue, depression stresses, improve the general well-being and mental state of patients. The essence of the biophysical process that occurs when magnetized water is ingested is that when it enters the body cavity, it is destructed and loses its “magnetization” with the release of previously accumulated energy. The quanta of the released magnetic energy are absorbed by the surrounding cells, and magnetically dependent reactions are activated in them. This has a positive effect on metabolism. There is a replenishment of magnetic energy, usually supplied to the body from the Earth's magnetic field.

According to Professor Lane (Israel Institute of Technology), since magnetized water increases the solubility of minerals, it improves the supply of the entire body with nutrients, which positively affects the general condition of a person. For many years, practitioners in India, Japan, Russia and other countries have successfully used magnetized water to treat various diseases, restore impaired metabolism, increase overall energy levels and improve people's health. In one of the clinics in St. Petersburg, patients suffering from kidney and gallstone diseases drank magnetized water, and it contributed to the washing out of salts and small stones. By chemical composition, these stones are oxalate salts, phosphates or urates with layers of mucous substance. Stones grow irregularly shaped, have sharp corners and edges. Magnetized water smoothes the stones, causing them to crack and grind. The size of the liver is reduced, the gall bladder becomes less rigid. All this helps to reduce pain.

Magnetized water generally strengthens the immune system and has been shown to be effective in treating colds, flu, and coughs. Regular consumption of manicured water prevents the growth of the cholesterol layer in the arteries and their hardening (which is fraught with increased pressure), helps to maintain normal heart function. It also alleviates the condition in asthma and many other diseases.

Candidate of Medical Sciences R.I. Mikhailova at the Central Research Institute of Dentistry found that irrigation (rinsing) with magnetized water helps to remove tartar, eliminate periodontal disease, and treat phlegmon. Magnetized water prevents the formation of dental plaque, cleans enamel from soft plaque, and stops bleeding gums. S.I. Dovzhansky (Saratov) has achieved significant success in using this water for various skin diseases.

Scientists claim that such water helps lower blood cholesterol and helps the resorption of cholesterol plaques on the walls of blood vessels. An important feature of magnetic water can be called its ability to normalize metabolism and regulate blood pressure. In combination with living water, magnetic water can help renew cells in the body and thus strengthen the human immune system.

This unusual water has a very beneficial effect on the skin and even (according to all the same scientists) can partially slow down aging. Given that magnetic water stimulates the metabolism, it is indispensable for helping the body in weight loss. This very attractive quality of magnetic water can be used to maintain the body's strength during fasting or a serious diet.

A very useful property of magnetic water can be called the positive effect that it has on the process of crushing stones in the gallbladder. Magnetic water is an excellent cleanser. If there are already many effective means for removing toxins from the body, magnetic water can solve the more difficult task of removing excess toxins and salts from the body. The dosage of magnetized water for oral administration is three quarters of a glass at a time. In total, you need to take it 3 times a day in between meals. In the field of external use, magnetic water is usually used for lotions, douches or compresses, indications of which are wounds, dermatitis, skin rashes in case of allergic reactions. It is also good to sometimes take baths with magnetic water to maintain health and beauty, however, you should not get carried away with the latest procedure.

It is very good to brew tea on magnetic water - it will acquire a great taste and retain a tonic effect longer. Herbal preparations brewed on this water will enhance their healing properties and increase the effectiveness of the action. You can even drink medicine with magnetic water, so that they are better absorbed by the body and do less harm to healthy organs. Magnetized water helps the proper absorption of calcium, so it is useful to give it to adolescents who have intensive bone formation.

Treatment of anemia with magnetic water.

Drink magnetic water daily with barberry juice and honey. To prepare a healing mixture, take a tablespoon of each. Use three times a day for 15 days. 2. 250 ml of apple juice, 100 ml of grape juice and magnetic water. Drink a glass twice a day before meals. 3. prepare an infusion of feijoa fruits - finely chop two fruits. Brew a glass of boiling water, stand for an hour. Add 100 ml of magnetic water to the filtered, take three times half a glass to treat anemia. 4. mix carrot and beet juices taken in 100ml, add healing magnetic water and a tablespoon of fresh lemon juice and rosehip syrup. Use an effective remedy for the treatment of anemia for a week at 50ml. 5. steal 400 ml of boiled water in a thermos 100 g of gooseberry fruit, a tablespoon of dried currants and rose hips. Leave overnight, strain in the morning, add 200ml of magnetic water. Drink 220ml half an hour before meals for a month.

Treatment of arrhythmias by magnetic water.

Tablespoon of the mixture of the colors of the leaves and berries of a hawthorn to fill in a thermos, pour boiling water — 400 ml. The composition of decanting in half an hour, mix with the magnetic water — 200ml. Drink 200 ml three times per day.2. berries cranberries — 2st.l., the herb lemon balm — 1st.l. steamed Cup of boiling water. To withstand 30 minutes, pour a glass of magnetic water. Take half glass three times throughout the month. The tool is strong, so a break of 14 days. Further, if necessary, repeat the treatment. 3. two tablespoons of ripe cranberries, a tablespoon of marigold colors to brew a half Cup of boiling water, let stand an hour, add treatment magnetic water — half Cup. To take 21 days, three times per day. 4. tablespoon dried fruit of viburnum berries and leaves of bilberry, color hawthorn and chamomile, grass motherwort and series, add corn silk to make a half Cup of boiling water, heat wrap, let stand 30 minutes. To connect with 100 ml of infusion and half a glass of magnetic water. The composition is useful to drink half a Cup three times per day.Arthritis treatment magnetic 1/. taken mix a teaspoon of the roots, the leaves of dandelion. Add a tablespoon of dried cranberry berries. A teaspoon of the mixture brew a half Cup of boiling water, let stand 20 minutes. In the strained infusion pour 100ml magnetic water. Take 15 days a quarter of a Cup for 40 minutes before eating.2. dried cherries, a teaspoon of good green tea to make a glass boiling water, let stand for 10 minutes. To the filtered composition pour half a glass of magnetic water. Take half of the month, daily a glass before meals.

Use of magnetic water in atherosclerosis.

A quarter Cup of freshly made cherry juice to dilute the same amount of magnetic water. Drink 50 ml three times before eating. After half a month, make a break for 7 days, then the treatment can be repeated with the same interval more than once.2. more effective for the treatment, prevention of atherosclerosis happens when the mixture of magnetic water and cherry juice to add a little honey, fresh lemon juice — at the 1st.l. each. Such a composition a week for drink 100ml three times a day. Then rest 2 weeks, then repeat the treatment.3. tablespoon of the mixture, berries, strawberry leaves to brew a half Cup of hot water, let stand for 24 minutes. Then add 100ml of water magnetic. To drink in 50 minutes after eating a Cup of infusion. If no leaf can take 2st.l. berries, to withstand a water bath for about 5 minutes, add to the cooled composition at a magnetic water — 100ml.4. brew taken a tablespoon of viburnum berries and the flowers of the chestnut 800ml of boiling water, drain after 1/2hour. When slightly cooled pour into the magnetic infusion 300ml water. The tool is strong, use half of the month 2st.l. after a meal in half an hour.Treatment of gastritis magnetic 1/. brewing 300g fresh cranberries 800ml of boiling water, boil for 10 minutes, close tightly, let stand for an hour. To medium pour 300ml magnetic water. To use the composition from gastritis 100 ml three times before eating.2. mix dried berries, cranberries, strawberries, 4st.l. marjoram, on 3st.l. herbs rosemary, bearberry, add 2st.l. Highlander snake and a tablespoon of sweet flag root. Tablespoon of herb collection pour 100ml of boiling water, stand an hour, add minichannel water — 100ml. Use 50ml pharmaceutical infusion three times before eating.

Treatment of gastritis with magnetic water.

Brew 300g of fresh lingonberry 800ml boiling water, boil for 10 minutes, close tightly, let stand for an hour. Add 300 ml of magnetized water to the product. Use the composition from gastritis 100ml three times before meals. 2. mix the dried berries of lingonberries, wild strawberries, 4 tbsp. oregano herbs, 3 tablespoons each Ledum herbs, bearberry, add 2 tbsp. snake highlander and a tablespoon of calamus roots. A tablespoon of herbs collection pour 100 ml of boiling water, stand for an hour, add magnetized water - 100 ml. Drink 50ml of medicinal infusion three times before meals.

References: magnetic field water medicine


1. Aliev D.A., Aliev Yu.A. Errors in the diagnosis of osteogenic sarcoma. // Surgery. 1987. No. 10 p. 117 119.

2. Amiraslanov A.T. Complex methods of treating patients with osteogenic sarcoma. // Thesis. doctors honey. sciences. Moscow, 1984.

3. Annamuhamedov A. Fibrosarcoma and malignant fibrous bone histiocytoma: clinical presentation, diagnosis, treatment and prognosis. // Thesis. Cand. honey. sciences. Moscow, 1986. 193p.

4. Balaev I.I. Conservation and recovery operations using transosseous osteosynthesis in the treatment of patients with primary tumors of long tubular bones. // Abstract of diss. .Doctors honey. sciences. Moscow, 1998.37s.

5. Bauman KV, the case of resection of the upper limb in the shoulder joint // Khir. Velyaminov archive. 1914.Vol. 30. Book. 1, p. 145.

6. Berma A. M. materials on the pathological anatomy of synoviomas. Abstract. diss. Cand. sciences. M., 1966.

7. Bizer V. A., Mardinsky Yu. S. Malignant tumors of the pelvic bones in children // Damage. and ill, pelvic bones in children. M .: CITO, 1969.S. 212-217.

8. Bizer V. a., Timukhina V. N. Radiation treatment of a localized form of Ewing's sarcoma in children in combination with polychemotherapy // Vopr. oncology .- 1982; - XXVII.- No. 7.- S. 45-49

9. Bizer V. A., Timukhina V. N. Luchevok treatment of a localized form of Ewing's sarcoma in children in combination with polychemotherapy. Oncology issues. 1982.V.28. No. 7. S. 45-49.

10. Bliskunov A. I., Leikin M. G. et al. Hip lengthening with Bliskunov apparatus using various types of osteotomies. Vestn. traumatol. orthopedist. - 1996.- No. 3 11. Blokhin N.N., Translatorova N.I. Chemotherapy of tumor diseases. Moscow. 1984. 303 s.

12. Bogoraz N. A. L. Restorative surgery. M., 1949. Part 2. T.

13. Bogoraz N. A. Reconstructive surgery. Part 2, T. 2.1. M., 1949

14. Bordyushkov Yu.N., Vagner V.P. To the mechanism of the indirect influence of the magnetic field on the tumor process. // Autolymphochemotherapy and other oncology issues. Moscow. 1997.S. 284-286.

15. Burdygin VN Parostal sarcoma (clinic, diagnosis, treatment): Diskand. honey. sciences. M., 1947

16. Burdygin V. N. Parostal sarcoma. (Clinic. Diagnosis. Treatment) // Diss. honey. sciences. M., 1974

17. Buchachenko A.L., Sagdeev R.Z., Salikhov K.M. Magnetic and spin effects in chemical reactions. Novosibirsk 1978. p.296.

18. Vashkevich LB The role of endovascular interventions in the diagnosis and comprehensive treatment of patients with sarcomas of soft tissues and bones. // Abstract of diss. .kand. honey. sciences. Minsk, 2004.23s.

19. Vinogradova T. P. Classification and questions of microscopic diagnosis of bone sarcoma // Diagnostics of bone sarcoma. M., 1965.S. 7-20

20. Vinogradova T. P., Berman A. M. About chondromyxoid bone fibroma. Surgery. 1960. No.6. from. 128-131 21. Vinogradova T. P., Berman A. M. chondrosarcoma fibroma of bones// Surgery.- 1960-No. 6.- P. 128-131

22. Vinogradova T. P., Lavrentieva G. I. Regeneration and transplantation of bone. M.: Medicine, 1974. S. 245

23. Vinogradova T. P., lavrischeva G. I. Regeneration and transplantation of bone. M.: Medicine, 1974

24. Vinogradova T. P., V. J. Schlapobersky Of the predictive value of the options structure with myeloid sarcomas.// Ortoped., traumatol. and the prosthesis. 1966. No. 6, P. 17-22

25. Vinogradova T. P. tumors of bone. M. Medicine, 1973. 336 p. Vinogradova T. P. Tumors of the joints, tendons, fascia, aponeurosis. M. Meditsina, 1976. 235с.

26. Vinogradova T. P. Trauma and tumor.// Archives of pathology. 1976. No. 9. p. 76-84.

27. Volkov M. V. Primary bone tumors in children. Raspoznanie. 1962

28. Volkov M. V. diseases of bones at children. M. Medicine, 1988.630 S.

29. Volobuev A. N., Zhukov B. N., Ovchinnikov E. JL, Trufanov JI.A. Spin mechanisms influence the production of a magnetic field on the transfer of a nervous impulse. // Magnetology 1993. No. 1. page 3 7.

30. Gabrilovich M. I. a Status of average weight molecules in blood plasma in some infectious diseases of viral and bacterial nature. The author's abstract Diss. . Cand. Med. Sciences. Nalchik 1998. 22C.

31. Gabrielian N. And. et al. Diagnostic value of determination of middle molecules in blood plasma PR nephrological diseases //Clinical medicine. No. 10. 1981. p. 38 42.

32. Gabrielian N. And. et al. Middle molecules and the level of endogenous intoxication in the intensive care patients //Anesthesiology and reanimatology. No. 1. 1985. p. 36 38.

33. Galkina Y. S. Autohemotherapy in treatment bolnyh malignant soft tissue tumors. The author's abstract Diss. . Cand. Med. Of Sciences, Rostov-on-don, 2000, 21C.

34. Garin A. M., of Klebnov A. V., tabagari D. Z. Handbook of anticancer drug therapy. Moscow. 1993. 199с.

35. Gershanovich M. J1. Complications of chemo - and hormonotherapy of malignant tumors. Moscow. 1982. 222с 36. Gershanovich M.L., Filov V.A., Akimov M.A., Akimov A.A. Introduction to the pharmacotherapy of malignant tumors. St. Petersburg. 1999.142s.

37. Golotina L.Yu. Prolonged intraperitoneal chemotherapy in the complex treatment of advanced ovarian cancer. Diss. . Cand. honey. sciences. Rostov-on-Don. 1995.148 s.

38. Goldstein L. M., Olshanetsky A. S., Prokofiev E. I. On the long-term results of treatment of patients with bone sarcomas // Tr. XXXVI All-Union. congress of surgeons. 1960.M .: Medgiz., 1962.S. 499-503

39. Goldstein L. P., Olshanetsky A. S., Prokofiev E. I. On the long-term results of treatment of patients with bone sarcomas // Transactions of XXVI All-Union. Congress of Surgeons (1960). M .: Medgiz, 1962.-S.499-503

40. Gubler E.V. Computational methods for the analysis and recognition of pathological processes. Leningrad. 1978. 41. Davydovsky IV. General human pathology. M.G. Medgiz., 1961.S. 439

42. Davydovsky IV. General pathology of man. M.: Medgiz, 1961

43. Demetsky A.M. A modern understanding of the mechanisms of action of magnetic fields. // Magnetology 1991. No. 1. from. 6 - 11.

44. Dymarsky L. Yu. Results of surgical treatment of patients with malignant tumors of the scapula and soft tissues of the scapular region. Oncology issues. 1955. No. 1. S. 6-27

45. Eremina JI. A., Karapetyan R.M., Makhson A.N., Sinyukov P.A. Tumors of the musculoskeletal system // Handbook of Oncology. 4th ed. reslave. and add. / Ed. Acad. N. N. Trapeznikova and prof. and. B. Poddubnoy. Kappa Publishing House, 1996. 152-175

46. ​​Eremina L. A., Sinyukov P. A., Slonimskaya E. M. Therapy and prognosis in Ewing's sarcoma. Oncology issues. 1986.V. 32.№5. S.29-36

47. Eremina L. A., Sinyukov P. A., Slonimskaya E. M. Therapy and prognosis in Ewing's sarcoma // Vopr. Oncol.-1986.-ХХХІ.-№5.-С.29-36

48. Eremina L. A., Khmelev O. N., Khojamuratov D. X. et al. Clinical and radiological characteristics of a giant cell tumor of the bone. Oncology issues. 1985.Vol. 31. No. 9. S.21-27

49. Zheravin A.A. Organ-preserving operations using intraoperative radiation therapy for bone tumors. // Abstract of diss. .kand. honey. sciences. Tomsk, 2002.25s.

50. Zalozhneva 3. D. On the question of the interscapular-thoracic amputation in malignant neoplasms of the shoulder-scapular region. Kazan, honey. journal 1926. No. 8. S. 316-323 51. Zatsepin S. T., Kuzmina L. P., Makhson N. E. Periarticular bone resections in a bone pathology clinic // Actual. questions traumatol. , orthopedist. M.: CITO, 1970. S 88-93

52. Zatsepin S. T., Kuzmina L. P., Makhson N. E. Periarticular bone resections in the clinic of bone pathology // Actual ~ questions of traumatology and orthopedics. M .: CITO, 1970.- S. 88-93

53. Zatsepin S. T., Makhson A. N. Removal of the whole humerus with endoprosthetics of the defect in cancer patients: Method, recommended. M., 1980.

54. Zatsepin S. T., Makhson N. E. Tumors of the pelvic bones of adults (Clinic. Diagnosis. Treatment) // Mater, Plenum of the All-Union. total traumatol., orthopedist. M., 1968.S. 4-6

55. Zatsepin S.T. Bone pathology in adults: a guide for doctors. Moscow, Medicine. 2001.664 s.

56. Zatsepin S.T. Preserved surgery for bone tumors. Moscow. Medicine, 1984. 288s.

57. Zubkova T.V., Tarnapolskaya O.V. Assessment of physico-chemical characteristics of blood and lymph cells to control the immunomodulating effectiveness of AHCT and AJTXT // New methods of intensive care for cancer patients. Moscow. 2000.S. 138 141.

58. Ivanova S.M. Some biophysical aspects of the mechanism of action of magnetic fields on the structural components of blood. // The use of magnetic fields in medicine, biology and agriculture. Saratov. 1978. p. 27 28.

59. Ivkov V.G., Berestovsky G.N. Lipid bilayer of biological membranes. Moscow 1982. 224s.

60. Ishanhodzhaev U. U. Prediction factors for malignant bone tumors. // Abstract of diss. . doctors honey. sciences. Moscow, 1993.40s. 61. Kagramanov S. V. Gulkevich K. Yu. Chondrosarcoma of the upper jaw, growing into the lumen of the superior vena cava, cardiac cavity and pulmonary artery // Archive Pat. 1967. No. 2. S. 76-78

62. Kasumov N.V. Factors that determine the prognosis in patients with chondrosarcoma. // Thesis. Cand. honey. sciences. Moscow, 1984. 238p.

63. Klimova M.K., Areberg A.A. On malignancy of individual foci with dyschondroplasia // Orthopedist. traumatol.-1964.-No3.-C. 50-58

64. Klimova M.K., Arenberg A.A. On malignancy of individual foci with dyschondroplasia. Orthopedist., Traumatol. and a prosthesis. 1964. No3. from. 50-58.

65. Klimova M.K., Nechvolodova O. L., Adrianova E.K. D.Pardina E.V. On the difficulties of radiological diagnosis in diseases of the pelvic bones // Damaged. and sickness, pelvic bones, m.: CITO, 1969 S. 163-168

66. Knysh I.T., Korolev V.I., Fatty B. B. A. Cartilage tumors. Kiev: Health, 1986, 366p.

67. Knysh I.T., Korolev V.I., Tolstopyatov B.A., Bakhtiyarova V.I. Some issues of diagnosis and treatment of pelvic bone tumors // Damaged. and ill, pelvic bones. M .: CITO. 1969 No. 17. 175-190

68. Kobina S.A. Comprehensive diagnosis of juxtacortical bone sarcomas in children. // Abstract of diss. .kand. honey. sciences. Moscow, 1998.19s.

69. Kovalev D.V. Organ-preserving operations at the present stage of combined treatment of osteogenic sarcoma of long tubular bones in children. Bulletin of Traumatology and Orthopedics. 2000, No. 2, p. 76-79.

70. Comprehensive treatment of bone tumors. Edited by A. Korzh 71. Kuzmina L. P. Features of the clinical course of pelvic chondrosarcoma // Damage and disease of the pelvic bones. M.: CITO, 1969.-S.158-163

72. Kuzmina L. P. Features of the clinical course of chondrosarcoma of the pelvic bones // Damaged. and ill, pelvic bones. M .: CITO, 1969.S. 158-163

73. Kuzmina L. P. Osteoblastoclastomas (giant cell tumors) of long tubular bones (Clinic. Diagnostics. Treatment) Diss. Doctor. honey. sciences. M., 1969

74. Lavrishcheva G. I. Reparative regeneration of bones in different conditions: Dis. Dr. med. sciences. M.1969

75. Lagunova I. G. Tumors of the skeleton. M., 1962

76. Lynbnrg B. E. Resectio interscapulo-thoracica according to Tikhonov-Linberg // Tr. XIX Congress grew. hirkrgov. L., 1928. P.315

77. Lipkin S. I. Clear cell chondrosarcoma of the bone // archive pat. 1983. 38.P. 44-50

78. Lisutin A.E. Autohemochemotherapy combined with extracorporeal magnetic blood treatment in the complex treatment of breast cancer. Dis. . Cand. medical science 120 C.

79. Makhson A. N. About adjacency surgery in bone oncology. Orthopedist., Traumatol., Prosthesis. 1991 No. 2 S. 53-57

80. Makhson A. N. About adequate surgery in bone oncology // Orthopedist, traumatol.-1991.-№2.-S.53-57 Kiev, “Zdorovya”, 1979. 224 p. 81. Makhson A.N. Operations on Godogoraz and Tikhov-Linberg as adequate interventions for malignant bone tumors // Surgery.- 1990.-No. 9.- P.45-48

82. Makhson A. N. Savings operations in patients with metastases in long tubular bones // Thes. doc. symposium on bone tumors. Vilnius, 1980

83. Makhson A. N. Surgical treatment of patients with metastatic lesion of long bones, oncology issues. 1981. No. 4

84. Mahson A.N., Zack B.I. Die Behandlug des fortgeshrittenen Nieren karzinomas.//Z.Urol, u. Nephrol. 1981. Bd 74. S. 667-669

85. Machson H. E. Iliac-abdominal resection of the anterior pelvic ring. Surgery. 1970. No. 12. S. 98-103

86. Makhson N.E., Lipkin S.I. Parostal iliac sarcoma. Oncology issues. No. 10. S. 87-89

87. Makhson N.E., Makhson A.N. About radical safe operations for tumors of the scapula. Oncology issues. 1984. 34 71-75

88. Machak G.N. The immune status of patients with osteogenic sarcoma and Ewing sarcoma. // Abstract of diss. .kand. honey. sciences. Moscow, 1992.24s.

89. Nino Castellanos H.E. Comparative evaluation of various types of surgical intervention for bone sarcomas.

90. Oboznaya E.I., Vishnevsky V.I., Skornyakov B.A., Stus L.K., Obozny E.P. The mechanism of action of a magnetic field on some indicators of intracellular metabolism // Cryobiology and Cryomedicine. 1982. V. 10. p. 40-43. 91. Odessa-Melnikova J1. A., Odessa O. N. On malignancy of a giant cell tumor (osteoblastoclastoma) of bones. Oncology issues. 1960. No9 S. 49-52

92. Olshanetsky A. S. On the results of the interscapular-thoracic resection in case of malignant tumors of the shoulder-scapular region. Surgery. 1962. No. 5. S. 73-76

93. Pelekhin P. P. Nerve hatching, huge cell stump sarcoma, scapular hatching. Death // Honey News. 1866. No8

94. Translators N. N. Antitumor chemotherapy. Moscow. 1996.222s.

95. Petrov N.N. BME. 2nd ed. M., 1962.V. 24.P. 55- 57

96. Petrov N. N. Interscapular-thoracic resection // New. chir. archive. 1936.V. 37. Prince Z. No. 10. S.511-512

97. Petrov N. N. The main issues of the appearance and growth of tumors // Vopr. Onkol.-1956.-T.2.-No3.-S. 236-274

98. Petrovichev N. N. Chobanyan N. S., Annamuhamedov A., Khodzhamuratov D. X. On the histogenesis of malignant histiocytoma and giant cell bone tumor // Archive Pat. 1985. Issue. 7. S. 11-16

99. Petrovichev N.N., Annamuhamedov A. Clinical and morphological analysis of bone fibrosarcoma: (Retrospect. Research.). Oncology issues. 1984. No. 8. S. 52-57

100. Petrovichev N.N., Annamuhamedov A. Clinical and morphological analysis of bone fibrosarcoma (retrospect. Research) // Vopr. Onkol .- 1984.- No. 8.- S. 52-57 101. Petrovichev N.N., Eremin J1. A., Khmelev O.N., Kasumov N.V. Low-differentiated (dedifferentiated) chondrosarcoma. Oncology issues. 1984. No. 1. S. 8-13

102. Polyanichko M.F., Bagdasarova I.E. Adjuvant and neoadjuvant AHCT in the complex treatment of kidney cancer // High Technologies in Oncology. Materials of the 5th All-Russian Congress of Oncologists. Kazan. 2000.V.2. S. 333-334.

103. Polyanichko M.F., Raevsky V.A. AGHT in the complex treatment of testicular malignancies // High Technologies in Oncology. Materials of the 5th All-Russian Congress of Oncologists. Kazan. 2000.V.2. S. 333-336.

104. Presman A.S. Electromagnetic fields and wildlife. Moscow. 1968.

105. Protsenko L.D., Bulkina Z.P. Chemistry and pharmacology of synthetic antitumor drugs. Kiev, 1985.265s.

106. Radchenko A.A. Epidermal growth factor receptors, EGF-like peptides and glucocorticoid receptors in osteogenic sarcoma. // Abstract of diss. .kand. honey. sciences. Moscow, 1997.27s.

107. Rakov A. I. the basic principles of modern surgery of malignant tumors. Surgery. 1968. No. 1. S.1-7

108. Rakov A. I. The basic principles of modern surgery of malignant tumors // Surgery.-1968.-№1 S. 1-7

109. S. Reinberg S. A. Radiodiagnosis of diseases of bones and joints. M., 1964

110. Reinberg S. A. Radiodiagnosis of diseases of bones and joints. M., 19111. Rusakov A. V. Guide to pathological anatomy. M., 1959. T.5. S. 418

112. Ryzhkov A.D. Integrated radionuclide diagnosis of osteogenic sarcoma. // Abstract of diss. .kand. honey. sciences. Moscow, 1997.

113. Salatov R.N. Possibilities of magnetotherapy in an oncology clinic. // 1 congress of oncologists of the CIS. Moscow. 1996.p. 695.

114. Salatov R.N. Treatment of cancer of the lower lip and facial skin with a magnetic field. // Abstract of thesis. . Cand. Honey. Science. Moscow. 1982. 17s.

115. Salatov R.N. Magnetotherapy in the treatment of inflammatory processes and malignant neoplasms. Abstract. Dis. . Dr. med. sciences. Rostov-on-Don. 2001.51s.

116. Salatov R.N. Magnetotherapy in oncology. // IY All-Russian Congress of Oncologists: thesis. Doc. Rostov-on-Don. 1995.S. 517 - 519.

117. Salatov R.N., Vashchenko L.N., Kechedzhieva E.E. Magnetotherapy as a factor in antitumor protection and treatment for cryotherapy of malignant tumors // Methods and mechanisms for increasing antitumor protection in oncology. Moscow 1993. p. 144.

118. Salishchev E. G. hatching of the entire lower limb with its nameless bone (exarticulatio interileo abdominalis) // Doctor. 1899. No. 25. S. 721-722; No. 26. S. 757-761

119. Samokhina L.A., Baygutanov Zh.B. Zheksenbiev N.Zh. The biological effect of electromagnetic fields. Pushchino. 1982. 167 p.

120. Selivanov VP On the surgical treatment of tumors of the pelvic bones. Orthopedist., Trauma. and a prosthesis. 1964. No3 S. 58-6364 121. Sidorenko Yu.S. Autohemochemotherapy. Rostov-on-Don, 2002.236s

122. Sidorenko Yu.S., Katsman M.V., Aizenshtark E.A. et al. The value of AHCT with preliminary radiation in the treatment of ovarian cancer // Questions of clinical oncology and neuroendocrine disorders in malignant neoplasms. M. 1982. S. 46-50.

123. Sidorenko Yu.S., Maksimova N.A., Shubin B.V., Complex X-ray sonographic diagnosis of bone and soft tissue tumors. Kiev 2000.

124. Sidorenko Yu.S., Shatova Yu.S. Possibilities of using autohemochemotherapy in patients with malignant tumors of soft tissues. // In the collection "Modern technologies in oncology"; Rostov-on-Don, 2000, p. 213-217.

125. Sidorenko Yu.S., Maksimova N.A., Shubin B.V., Complex X-ray sonographic diagnosis of bone and soft tissue tumors. Kiev 2000.

126. Sinyukov P.A. Modern approaches to chemotherapy of osteogenic sarcoma. // Abstract of diss. . Doctors Abstract .kand. honey. sciences. Moscow honey sciences. Moscow, 1993.49s.

127. Soloviev Yu. N., Eremin JI. A., Petrovichev N.N. Mesenchymal chondrosarcoma (clinical and morphological study). Oncology issues. 1983. No. 9. S. 21-25

128. Soloviev Yu. N., Eremin JI. A., Petrovichev N.N. Mesenchymal chondrosarcoma (clinical and morphological examination) // Vopr. Onkol.-No9.-S.21-25

129. Tikhov P.I. Case of interscapular-thoracic resection // Khir. Velyaminov archive. 1914. Book. 1

130. Tikhov P. I. Private surgery. Pg., 1917. T.Z. S. 438 131. Tikhov P.I. private surgery. Petrograd, 1917.-T.Z.

132. Trapeznikov N. N., Amiraslanova A. T., Petrovichev N. N. and others. Forecasting factors in parostal sarcoma. Oncology issues. 1990. No. 7. S. 805-811

133. Trapeznikov N. N., Grigoryeva T. M. Primary pelvic bone tumors. M., 1978

134. Trapeznikov N. N., Eremina L. A., Amiraslanova A. T. et al. Role of safe operations in the complex treatment of patients with osteogenic sarcoma. Surgery. 1986. No. 10. S. 113-119

135. Trapeznikov N.N., Eremina L.A., Kutateladze T.O. Survival under the conditions of adjuvant chemotherapy in patients with osteogenic sarcoma. Oncology issues. 1984. No. 7. S. 33-40

136. Trapeznikov N.N., Soloviev Yu.N., Eremina L.A., Amiraslanova A.T. Sarcomas of bones. Tashkent: Medicine, 1983

137. Trapeznikov N. N., Tseshkovsky M. S., Tarasov B. P. On the treatment of patients with osteogenic sarcoma, orthopedist., Trauma. and a prosthesis. 1965. No. 5. S. 32-37

138. Trapeznikov N.N., Tseshkovsky M.S., Tarasov B.P. On osteogenic parostal sarcoma. Surgery. 1966. No. 10. S. 112-1G4

139. Trapeznikov N.N., Tseshkovsky M.S., Tarasov B.P. On osteogenic parostal sarcoma // Surgery.-1966.- No. 10.- P. 112-114

140. Trapeznikov NN, Soloviev Yu.N., Eremina L.A. et al. Progress in the treatment of osteogenic sarcoma // Vestnik ONTS AMS Rossii.-1993.- © l.-C.3-9. .141. Trapeznikov N.N., Soloviev Yu.N., Eremina L.A., Amiraslanov A.T. Bone sarcomas: clinic, diagnosis, treatment. Tashkent: Medicine. 1983. 314 p.

142. Fedorova E.N. Morphological evaluation of various methods of modern treatment of osteogenic sarcoma. // Abstract of diss. .kand. honey. sciences. Moscow, 1982.29s.

143. Kharatishvili T.K. Primary bone reticulosarcoma: diagnosis, treatment, prognosis. // Abstract of diss. .kand. honey. sciences. Moscow, 1988.23s

144. Kharatishvili T.K. Bone chonrosarcoma: clinic, diagnostics, treatment, prognosis. // abstract of diss. . doctor, honey sciences. Moscow, 2000.56s.

145. Khatyrev S.A. Prediction factors for osteogenic sarcoma under the conditions of neoadjuvant and adjuvant chemotherapy. // Abstract of diss. .kand. honey. sciences. Moscow, 1997.29s.

146. Herobyan F. A., Tager I. L. Tumors of Ewing. Yerevan: Hayastan, 1973

147. Tsikhiseli G.R. Paraostal sarcoma: clinic, diagnosis, treatment. // Abstract of diss. .kand. honey. sciences. Moscow, 1980.23s.

148. Chaklin V. D. Tumors of bones and joints. M .: Medgiz, 1974.1. S.274

149. Chaklin VD Surgical approaches in the treatment of pelvic bone tumors. Orthopedist., Trauma. and a prosthesis. 1966. No. 2. S. 3-9

150. Chaklin V. D., Polyakov G. M. about the development of exostosis. Podiatrist, injury. and a prosthesis. 1964. No3. S. 44-50 151. Chilingaryants S.G., Zinkovich S.A., Kartashov S.Z., Nepomnyashchaya E.M., Zlatnik E.Yu. The use of the AHCT method in the combined treatment of locally spread lung cancer

152. High technologies in oncology. Materials of the 5th All-Russian Congress of Oncologists. Kazan 2000.V.2. S.351-352.

153. Shaak V. A. On the question of exartoculatio interileo-abdominalis // West. chir. 1927.T.10. Prince 30.S. 61-65

154. Shlapobersky V. Ya. Clinic and treatment of synoviomas. Surgery. 1962. 38. S. 119-127

155. Shlapobersky V. Ya. Clinical course, diagnosis, classification, and malignancy issues in osteoblastoclastomas // Osteoblastoclastoma. M., 1962

156. Shlapobersky V. Ya., Vinogradova T. P. Materials on the malignancy of benign pathological processes in the bones. Orthopedist., Trauma. and a prosthesis. 1969. No. 6. S. 48-54

157. Shlapobersky V. Ya., Kuzmina L. P. The current stage of the clinical study of giant cell tumors of bones (osteoblastoclast). Surgery. 1965. No. 4. S. 121-126

158. Shlapobersky V. Ya., Makhson N.E., Zatsepin S.T. Parostal osteomas (sarcoma). Orthopedist., Trauma. and a prosthesis. 1969. No. 12. S. 10-14

159. Shoikhet Y.N., Lazarev A.F., Shpigotsky A.N., Shpigotskaya P.A. Malignant bone tumors in the Altai Territory. Barnaul, 2004.183 s.

160. Shugabaker p. X., Malauer M. M. Surgery "sarcoma of soft ~ bone tissues. M: Medicine, 1996. S. 148-204 161. Shcherbakov S. D. Clinical evaluation of a comprehensive preoperative diagnosis of primary bone sarcomas of long tubular bones. Diss. . Cand. honey. sciences. Moscow, 1988.156 s.

162. Shcherbakov S.D. Safe operations in primary bone tumors of the extremities. // Abstract of diss. . doctors honey. sciences. Moscow, 1993.35s.

163. Encyclopedic dictionary of medical terms. M., Soviet Encyclopedia. 1984.-T.3.-C183

164. Yudin S. S. (Judin) Ilio-abdominal amputayion in case of sarcoma; recovery; pregnancy and birth of living child // Surg. Gyn and Obstetr. 1926. Nov. Vol. 43. No. 5 p. 668-676.

165. Yudin S.S. Indications and evaluation of major pelvic surgery. New surgery. 1926. T. 3. No. 1. S. 3-48

166. Bacci G., Ferrari S., Bertoni F. et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Instituto Ortopedico Rizzoli. J. Clin. Oncol. 2000. 18: 4-11.

167. Bacci G., Toni A. and all. long-term results in 144 localized Ewing's sarcoma patients treated with combined therapy // canaer (Philad.). 1989. Vol. 63. No. 8. P. 1477-1486.

168. Baldini M., Scotlani K., Barbanti-Brodano G., et al. Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome. N. Engl J Med. 1995; 333: 1380 1385.

169. Barness R., Catto M. chondrosarcoma of bone // J. Bone a J. Surg. 1966. Vol. 48. P. 729-964

170. Beck h. Erfahrungen mit der Hemipelvektomie bei malignen Tumoren // Munch, med. wochenschr. 1967. Bd 109.No 3. P. 126-130 171. Benjamin R. S. Chemotherapy for osteosarcoma // Bone tumors. Unni K.K., ed .- 1988.- P. 56-149.

172. Berger. Resection total (extirpation) de l'omoplate et de l'externe de la clavicule pur un sarcoma residive de l'epaule droite // Bull, et memoires de la Soc. de chirurgie de Paris. 1897. Vol. 23. P. 571

173. Berger. trios nouvaux cs amputation interscapulo thoraciques don't deux pratique es pour das tumeurs da l'extremite superieure de 1'humerus //Revue de Chir. 1905. Vol. 32. P. 187.

174. Bieling P., Rehan N., Winkler P., et al. Tumor size and prognosis in aggressively treated osteosarcomas. J. Clin. Oncol. 1996; 14(3): 848 858.

175. Bird, case of excision of Scapula, head of the humerus and part of the clavicule, for malignant diasease. loncet, Ldn 1865. Vol.2. —P.696

176. Borggeve. Knigelenksersatz durch das in der Beinlangsaehse um 180 gedrehte Fussgelenk// arch Orthop (Unfallchir) 1930.-28.-175.

177. Coley B. L. Neoplasma ofbone/2-d ed/NY 1960

178. Coley B. L., Higinbotham N., Romien C. Hemipelvectomy for tumors of bone, report of 14 cases // Amer. J. Surg. 1951.- № 82.1.-P.27-43

179. Copeland M. M.,Geschickter C. F. Chondroblastic tumors of bone, benign and malignant // Ann. Surg. 1949. P. 129-724

180. Copeland M., Geshickter C. F. Malignant bone tumor: primary and metastatic// Canaer. Part 1. 1963.№13.4 P. 149-155; Part 2.1963. №13.5. P.l87-196; Part 3. 1963. №13.6. P.232-238

181. Cotterill SJ, Ahrens S., Paulussen M., et al. Prognostic factors in Ewing s tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing s Sarcoma Study Group. J. Clin. Oncol. 2000; 18:3108 -3114.

182. Coventry M. В., Beabont J. W. Dedifferencierte of low-grade chondrosarcomas//Cancer (Philad.). 1971. Vol.28. P. 461-466

183. Dahlin D. C., Wells A. H., Henderson E. D. Chondromyxoid fibroma of bone. Report of two cases // J. Bone a. J. Surg. 1953. 35-A. P831

184. Dahlin D. C., Henderson E. D. Mesenchymal chondrosarcoma. Further observations on new entity// Canaer.-1962.- Vol.l5.-№2.-P.410-417

185. Enneking W. F. Local resection of malignant lesion of the hip and pelvis// J. Bone a. J. Sorg. 1966. 48-A. P.995

186. Enneking W. F., Dunham W. K. Resection and reconstruction for primary neoplasms involving the innominate bone // J. Bone Joint Surg. 1978. 60A.P.731-746

187. Enneking WF., Spanier S., Goodman M. A system for the surgical staging of musculoskeletal sarcoma. Clin Orth and Rel Reseach. 1980. No 153, 106-120.

188. Frei E., Jaffe N., Tattersall M. et al. New approaches to cancer chemotherapy with methotrexate // New Engl. Med.- 1975.- vol.292.- P.846-851.

189. Geschickter C. F., Copeland M. M. Parostenal osteoma of bone: a new entity // Am. Surg. 1951. 133.6. P. 790-806

190. Geschickter C. F.,Copeland M.M. Parostenal osteoma of bone: a new entity//Am. Surg.-1951.-133.6.-P.790-860

191. Ghormley R. K. Chondromas and chndrosarcomas of scapula and innominate bone //Arch. Surg. 1951. №63. P. 48-52

192. Glasser D. В., Lane J. M., Huvos A.G., et. al. Survival, prognosis, and therapeutic response in osteogenic sarcoma // Cancer -1992.-vol.69.-P.698-708.

193. Gordon-Taylor D., Monro R. S. Technique and management of hindquarteramputation // Brit. J. Surg. 1952. Vol. 39. №158. P.536-541

194. Gorlick R., Hubos AG., Heller G., et al. Expression of HER2/erbB2 correlates with survival in osteosarcoma. J. Clin. Oncol. 1999; 17:2781 -2788.

195. Hornicek FJ., Gebhardt MC., Wolfe M., et al. P-glycoprotein levels predict poor outcome in patients with osteosarcoma. Clin Orthop and Rel Research. 2000; 373:11 17.

196. Hutter R. V. P., Worcester I. n. and all. Benign and malignant giant cell tumors of bone //Cancer. 1962. Vol. 15. №4. P. 653-690

197. Huvas A. G., Butler F., Bretsky S. S. Osteogenic sarcoma associated Paget'sdisease of Bones. A clinicopathologic study of 65 patiens //Cancer (Philad). 1983. Vol. 52. №8. P. 1489-1495

198. Imbert R., Mosinger M., Gamel R. Cartilaginous tumors of bone // Surg. Gynec. andObst. 1962. 115.1.78

199. Jaff h. 1. Fray, Lichtenstein L. Chndromyxoid fibroma of bone. A destructurebenien tumor likely to be mistaken especially for chondrosarcoma // Arch. Path. 1948. 45.P. 541

200. Jaff N., Spears R., Eftekhari F. and all. Pathologic fracture in osteosarcoma. Impact of chemotherapy on primary tumor and survival//Cancer (Philad.). 1987. Vol. 59. №1. P. 701-709

201. Jaffe N., Frei E., Watts H., Traggis D. High-dose methotrexate in osteogenic sarcoma: a 5-year experience // Cancer Treat. Rep.- 1978.-vol. 62.-P.259-264.

202. Kotz. Современные методы лечения злокачественных опухолей// Вестн. травмато. ортопед.-1994.-№4.-Р.62-68

203. Krajbis-ModifiedJ., Van Ness. Rotationplasy in the Treatmen of malignant Neoplasms in the Lower Extremities of Children. Clin. Orthopaed and Related Res, 1991.-P.75-77

204. Lauchlan S. C., Waleh M. Reticulum cell sarcoma complicacing Paget's disease //Canad. Med. Assoc. J. 1963. №17. P. 891-892

205. Lexer E Joint transplantation and arthplastry// Surg. Gynec. a. Obst. 1925. № 40. P.782-809

206. Lichtenstein L., Jaff H. L. Chondrosarcoma of bone // The Am. J. of Pathol. 1943. Vol. 19. №4, July. P 533-537

207. Lichtensten L., Jaff h.L. Chondrosarcoma of bone // Am. J. Pathol.-1943.-Vol.XDC-№4.- P.53-573

208. Linberg В. E. Interscapulo-thoracic resection for malignant tumors of the scoulder joint region//J. Bonr and joint surg. 1928. №10. P. 344349

209. Link M.P., Goorin A.M., Miser A.W. et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of extremity. N. Engl. J. Med. 1986; 314: 1600 1606.

210. Londa S. K., Sareen P. M., Kalra V. В., Utreja S R. Synoviak sarcoma (a clinico-pathological study of 27 cases in twenty years)// Indian J. Cancer. 1983. Vol.20. №1. P. 23-26

211. Makhson A. Extralesional resection for tumors of the pelvis bones // Internat. Orthopaedics. (SICOT). 1997. P. 41-45

212. Malaver M.M., Dunham W.F. Skip metastases in osteosarcoma: Recent experience. J. Surg. Oncol. 1983; 22: 236 245.

213. Malawerr H. M., Dunham W.K. skip metastases in osteosarcoma recentexperience //J. Surg. Oncol.-1983.-Vol.22.-№4.-p236-245

214. Mankin HJ., Mankin CJ., Simon MA. The hazard of biopsy, revisited. J Bone and Joint Surg. 1997; 78A:659 663.

215. Marton Z. Malignus osteklastoma //Mag.Onkol. 1960. №4. P. 175181

216. Maximov A. Morphology of the mesenchymal reactions// Arch, patol. Lab. Mtd.1927. Vol.4. P. 557-606

217. McGann P. D., Flam M. S. Ewing's sarcoma of the phalangeal bone//J. Surg. Oncol. 1983. Vol. 22. №2. P.92-94

218. Mikami R. Histological study of osteogenic sarcoma by whole mount sectin//J. Jap Orthoped. Ass.-1964.-Vol.38.-№8.-p745-767

219. Mikami R. Histological study of the osteogenic sarcoma by whole mountsection//J. of the Japan. Orthoped. Assoc. 1964. Vol.38. №8. P.745-767

220. Morris D. M., House H. C. The singficance of metastasis to the bones and soft tissues of the handII J.Surg. Oncol. 1985. Vol.28. №2. P. 146150

221. O'Neal N. M., Ackerman L. V. Condrosarcoma of bone// Cancer. 1952. №5. P551

222. O'Neal N. M., Ackerman L. V/ Chondrosarcoma of bone // Cancer.- 1952.-№5.-P.551

223. Ottolenghi C. Massive ostearticular bone grafts (transplant of whole Femur)//J. Bone and Surg. 1956. Vol. 48. №13. P. 646-659

224. Peabody TD., Gibbs СР., Simon MA., Evaluation and staging of musculoskeletal neoplasms. J Bone and Joint Surg. 1998; 80A: 1204 1218/

225. Pizon R. La Presse Medici, 1963. №51. P2478-2488

226. Pratt С. В., Champion G. E., Senzer N. and all. Treatmen of unresectable or metastatic osteosarcoma with cisplatin-doxorubicin//Cancer. 1985. Vol.56. №8. p. 1930-1933

227. Provisor A., Nachman J., Krailo M. et al. Treatment of the nonmetastatic osteogenic sarcoma of the extremities with pre- and postoperative chemotherapy. Proc. Am. Soc. Clin. Oncol. 1987; 6: 217.

228. Ravitch M. M. Hemipelvectomy//Surg. 1949. №26. P. 199

229. Raymond A. K., Chawla S. P., Carrasco CH., et al. Osteosarcoma chemotherapy effect. A prognostic factor // Semin Diagn Pathol.- 1987.-vol.4.-P.36-212.

230. Recklinghausen F., Festschift R. die fibrose oder deformierende ostis,die osteomalacia, und die osteoplastiche carzinose in ihren gegenseiting beziehungen. Virchov zu seinem 71. Geburtstag gewidmet. Berlin G. Reimer, 1891

231. Robert W.H. Pho-microsurgical thechnique in orthopaedies, 1988.-P.74-77

232. Rosen G., Caparros В., Huvos A., et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvantchemotherapy based on the response of the primary tumor to preoperative chemotherapy//Cancer.- 1982.-vol.49.- P. 1221-1230.

233. Rosen G., Mury M., Huvos A. et al. Chemotherapy with adriamycin in primary treatment of osteosarcoma // Cancer. -1976.-vol.3 7.- P. 111.

234. Salser-Kuntshic M., Brand G., und Delling G. Bestimmung des morphologischen Kegressionsgrades nach Chemotherapie bei malignen Knochentumoren//Pathologe.- 1983.-vol.4.- P.135-141.

235. Schajowicz P. Tumors and Tumor-like Lessons of bone and Joints// Springerverlag: New-York, Heidelberg, Berlin, 1981. P.342-359, 361372

236. Schobinger van Schbingen R. Primery reticulum cell sarcoma of bone// Amer. Surg. 1951. Vol. 93. №1. P. 41-49

237. Scully SP., Temple HT., Okeefe RJ., et al. J. Clin. Oncol. 1995. 13(9):2336 2341.

238. Simon MA., Bierman JS. Biopsy of bone and soft-tissue lesions. J Bone and Joint Surg. 1993. 75A: 616-621.

239. Spratt I. S. the rates of growth of skeletal sarcomas// Cancer (Philad.). 1965. Vol. 18. №1. P. 14-24

240. Sundaram M., McDonald DJ. Magnetic resonance imaging in the evaluation of the solitary tumor of bone. Current opinion in Radiology. 1990; 2: 697 702.

241. Sundaram M., McDonald DJ. The solitary tumor or tumor-like lesion of bone. Top Magn Reson Imag. 1989; 1(4): 17 29.

242. Sundaram M., McGuir MH. Computed tomography or magnetic resonance for evaluating the solitary tumor or tumor-like lesion of bone. Skeletal Radiology. 1988; 17:393-401.

243. Syme I. On disarticulation of the scapula from the schoulder joint// Med. Chir. Tr. Lond. 1857. №1. P. 107-112

244. Troup I. В., Bickel W. H. malignant disease of the extremities treated by exarticulation// J. Done a. J. surg. 1960. 42-A. №6. P.1041-1050

245. Ward WG., Mikaelian K., Dorey F., et al. Pulmonary metastasis of stage IIB extremity osteosarcoma and subsequent pulmonary metastasis. J. Clin. Oncol. 1994; 12(9) 1849- 1858.

246. Winkler K., Beron G., Kotz R. et al. Neoadjuvant chemotherapy for osteogenic sarcoma: Results of cooperative German/Australian study. J. Clin. Oncol. 1984; 2: 617 624.

247. Wuisman P, Enneking WF. Prognonsis for patient who have osteosarcoma with skip metastasis. J Bone and Joint Surg. 1990; 72A(1): 60 -68.

248. Wunder JS., Bull SB., Aneliunas v., et al. MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study. J. Clin. Oncol. 2000; 18: 2685-2694/

249. Zatzepin S. Т., Machson N. E. Operative treatment in parosseal osteoma of femur//Opertive treatment of bone tumors. Verlag, Stuttgart. Ed. Shpchal G., 1970. p. 75-78


© 2018 Magnetic Technologies

UAE, Dubai


Office #202, Faisal Al Gurg Bldg.,

Oud Metha, 10th street

+971 4 3966639